SCHEMBL6367288

SCHEMBL6367288

CCC(=O)Oc1cccc2c1C(=O)c1cccc(OC(=O)CC)c1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.55
TTR P02766 3/20 0.52
POLM Q9NP87 2/20 0.49
POLK Q9UBT6 2/20 0.49
POLL Q9UGP5 2/20 0.49
POLH Q9Y253 2/20 0.49
EGFR P00533 1/20 0.49
PIM1 P11309 1/20 0.49
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
HTR2A P28223 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 2/20 0.47
USP2 O75604 2/20 0.47
ABCC4 O15439 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27602059 0.97 ELANE (0.56) ELANETTRPOLMPOLKPOLL
SCHEMBL6371722 0.87 POLM (0.57) ELANETTRPOLMPOLKPOLL
SCHEMBL27584372 0.84 ELANE (0.57) ELANETTRPOLMPOLKPOLL
SCHEMBL16473005 0.84 ALDH1A1 (0.62) ELANETTRPOLMPOLKPOLL
SCHEMBL6366589 0.83 POLM (0.71) ELANETTRPOLMPOLKPOLL
SCHEMBL27957751 0.82 POLM (0.46) ELANETTRPOLMPOLKPOLL
SCHEMBL7199740 0.82 ELANE (0.51) ELANETTRPOLMPOLKPOLL
SCHEMBL29019962 0.81 KCNA3 (0.51) ELANETTREGFRPIM1MEN1
SCHEMBL28326979 0.81 ALDH1A1 (0.47) ELANEPOLMPOLKPOLLPOLH
SCHEMBL27602070 0.81 POLM (0.68) ELANETTRPOLMPOLKPOLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM ELANE 1493/4885TTR 2364/4885POLM 946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.